LINCOLN
Invest with MTF
Invest Now
Invest in Lincoln Pharmaceuticals with 3.1X leverage
Performance
- Low
- ₹487
- High
- ₹501
- 52 Week Low
- ₹464
- 52 Week High
- ₹860
- Open Price₹499
- Previous Close₹497
- Volume10,478
Investment Returns
- Over 1 Month -0.53%
- Over 3 Month -7.89%
- Over 6 Month -12.73%
- Over 1 Year -42.6%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12.3
- PEG Ratio
- -0.7
- Market Cap Cr
- 983
- P/B Ratio
- 1.4
- Average True Range
- 13.72
- EPS
- 39.94
- Dividend Yield
- 0.4
- MACD Signal
- -7.86
- RSI
- 49.74
- MFI
- 66.87
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹490.55
-6.6
(-1.33%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹487.70
- 50 Day
- ₹501.61
- 100 Day
- ₹519.71
- 200 Day
- ₹548.77
Resistance and Support
492.92
- R3 512.73
- R2 506.92
- R1 498.73
- S1 484.73
- S2 478.92
- S3 470.73
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹490 As on 06 January, 2026 | 07:56
The Market Cap of Lincoln Pharmaceuticals is ₹982.6 Cr As on 06 January, 2026 | 07:56
The P/E ratio of Lincoln Pharmaceuticals is 12.3 As on 06 January, 2026 | 07:56
The PB ratio of Lincoln Pharmaceuticals is 1.4 As on 06 January, 2026 | 07:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.